Literature DB >> 8024404

Gleason histologic grading in prostatic carcinoma. Correlation of 18-gauge core biopsy with prostatectomy.

S E Spires1, M L Cibull, D P Wood, S Miller, S M Spires, E R Banks.   

Abstract

Histologic grading of adenocarcinoma of the prostate gland is a reliable predictor of extension and metastasis. Studies involving correlation of grade between biopsy and prostatectomy specimens have traditionally involved biopsies using a large-bore (14-gauge) cutting needle. However, common practice has shifted to the use of biopsy cores with a smaller caliber (18 gauge). This study was undertaken to determine the degree of correlation of tumor grade between 18-gauge core biopsy samples and excised glands. Sixty-seven patients with stage A or B adenocarcinoma of the prostate gland who had previously undergone 18-gauge core biopsy, who underwent radical prostatectomies, were studied. The Gleason score was determined by referred consensus among three pathologists. There was exact agreement between biopsy and excision in 39 cases (58%), whereas 24 cases (36%) differed by one digit. Three cases (4.5%) were undergraded, and one case (1.5%) was overgraded by two or more points. Only six tumors (8.9%) would have been incorrectly specified by the degree of differentiation. Discrepancies in grade of two points or more were not more frequent in cases with a small tumor volume (< or = 10%) in the biopsy specimens. We concluded that with careful histologic evaluation, the grade of tumor identified in these smaller biopsy cores correlates well with that seen at prostatectomy.

Entities:  

Mesh:

Year:  1994        PMID: 8024404

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

2.  Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.

Authors:  Gustavo E Ayala; Bahar Muezzinoglu; Kai H Hammerich; Anna Frolov; Hao Liu; Peter T Scardino; Rile Li; Mohammad Sayeeduddin; Michael M Ittmann; Dov Kadmon; Brian J Miles; Thomas M Wheeler; David R Rowley
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Direct cost for initial management of prostate cancer: a systematic review.

Authors:  C Sanyal; A G Aprikian; S Chevalier; F L Cury; A Dragomir
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

4.  Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; J.Edson Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 5.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

6.  Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer.

Authors:  Muhammad A Bulbul; Yaser El-Hout; Maurice Haddad; Ayman Tawil; Ali Houjaij; Nizar Bou Diab; Oussama Darwish
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

7.  Comprehensive microRNA Profiling of Prostate Cancer.

Authors:  Beatriz A Walter; Vladimir A Valera; Peter A Pinto; Maria J Merino
Journal:  J Cancer       Date:  2013-05-09       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.